BioLife Solutions BLFS 深 滬
已收盤 09-20 16:00:00 美东时间
25.77
+0.050
+0.19%
華盛通- 最 高26.05
- 今 開25.55
- 成交量 78.08万股
- 最 低 25.17
- 昨 收 25.72
- 總市值 11.67亿
- 52周最高 26.73
- 市盈率 靜 --
- 換手率 1.72%
- 52周最低 8.9201
- 委 比 91.70%
- 總股本 4530.00万
- 歷史最高 60.669
- 量 比 1.85
- 振 幅 3.42%
- 歷史最低 0.28
- 每 手 1
- 風險率 4.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?
David Iben put it well when he said, 'Volatility is not a risk we care about. W...
08-26 18:45
快讯 | BioLife Solutions公司：Benchmark将目标价从25美元上调至30美元
BioLife Solutions Inc : Benchmark Raises Target Price to $30 From $25
08-15 18:12
快讯 | BioLife Solutions Inc：斯蒂芬斯将目标价从27美元提高至30美元。
BioLife Solutions Inc : Stephens Raises Target Price to $30 From $27
08-12 13:39
快讯 | Jefferies将目标价从22元上调至26元，BioLife Solutions Inc。
BioLife Solutions Inc : Jefferies Raises Target Price to $26 From $22
08-09 15:30
BioLife Solns Raises FY24 Sales Guidance From $95.50M-$100M To $99M-$101M Vs. $105.79m
Raising full-year 2024 total revenue guidance to $99.0 million to $101.0 million; Cell Processing revenue guidance increased to $70.0 million to $71.0 million
08-09 04:59
BioLife Solns Q2 2024 Adj. EPS $(0.05) Beats $(0.14) Estimate, Sales $28.328M Beat $23.946M Estimate
BioLife Solns (NASDAQ:BLFS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.14) by 64.29 percent. This is a 61.54 percent increase over losses of $(0.13) per share from the
08-09 04:57
快讯 | biolife solutions第二季度营业收入为1800万美元，而IBES预计为2390万美元。
BioLife Solutions Q2 Revenue USD 18 Million Vs. IBES Estimate USD 23.9 Million
08-09 04:03
快讯 | biolife solutions展望2021财年营业收入美元指数9900-10100万
BioLife Solutions Outlook FY Revenue USD 99-101 Million
08-09 04:03
快讯 | biolife solutions报告2024年第二季度财务结果。
BioLife Solutions Reports Second Quarter 2024 Financial Results
08-09 04:03
